ScreenerHero

ALZCUR AlzeCure Pharma AB (publ)

STO · SE · Healthcare · Biotechnology · alzecurepharma.se
6.940SEK+1.17%Mkt Cap: 76.28M $P/E: 23.13

AlzeCure Pharma AB (publ) operates as a pharmaceutical company that develops small-molecule drug therapies for the treatment of severe diseases and conditions that affect the central nervous system. The company is involv…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$127.54BUSDP/E 29.3
MRNA
Moderna, Inc.
$81.13BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$74.79BUSDP/E 18.0
ARGX
argenx SE
$57.11BUSDP/E 34.8
ARGX
argenx SE
$55.24BUSDP/E 36.1
RVMD
Revolution Medicines, Inc.
$44.51BUSD
UCB
UCB SA
$41.63BUSDP/E 17.7
ONC
BeOne Medicines AG
$41.14BUSDP/E 64.7
RPRX
Royalty Pharma plc
$32.74BUSDP/E 30.1
ALNY
Alnylam Pharmaceuticals, Inc.
$29.42BUSDP/E 37.1
ROIV
Roivant Sciences Ltd.
$25.84BUSD
BNTX
BioNTech SE
$24.53BUSD
GMAB
Genmab A/S
$24.01BUSDP/E 30.3
INCY
Incyte Corporation
$23.13BUSDP/E 14.5
INSM
Insmed Incorporated
$22.67BUSD
GMAB
Genmab A/S
$21.61BUSDP/E 29.3
JAZZ
Jazz Pharmaceuticals plc
$15.32BUSDP/E 16.2
ASND
Ascendis Pharma A/S
$15.01BUSDP/E 17.5
EXEL
Exelixis, Inc.
$14.58BUSDP/E 18.6
SMMT
Summit Therapeutics Inc.
$13.78BUSD

Key Statistics

Company
Market Cap76.28M USD
Enterprise Value89.39M USD
Revenue (TTM)9.31M USD
Gross Profit9.31M USD
Net Income (TTM)-4.56M USD
Revenue/Share0.85 SEK
Last Price6.940 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees10
CountrySE
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)23.13
P/E (Forward)-57.17
PEG—
EV/EBITDA29.70
EV/Revenue9.60
P/S8.10
P/B10.35
EPS (TTM)0.30
EPS (Forward)-0.12
52W Range
1.30076% of range8.680
52W High8.680 SEK
52W Low1.300 SEK
Profitability
Gross Margin100.00%
Oper. Margin82.44%
EBITDA Margin32.33%
Profit Margin31.56%
ROE-144.75%
ROA-80.71%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.31M USD
CapEx (TTM)—
FCF Margin-64.56%
FCF Yield-7.88%
Net Debt-1.10M USD
Net Debt/EBITDA-0.36
Balance Sheet
Debt/Equity0.08
Current Ratio4.11
Quick Ratio0.70
Book Value/Sh0.66 SEK
Cash/Share0.10 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 SEK
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)13.00 SEK
Upside (mean)+87.3%
Target Range13.00 SEK – 13.00 SEK
# Analysts1
Ownership
Shares Out.114.91M
Float92.15M
Insiders39.58%
Institutions12.68%
Technical
SMA 507.198 (-3.6%)
SMA 2003.683 (+88.4%)
Beta-0.07
S&P 52W Chg14.58%
Avg Vol (30d)426.28K
Avg Vol (10d)181.08K
Technical Indicators
RSI (14)39.1
MACD-0.0612
MACD Signal0.0822
MACD Hist.-0.1434
BB Upper8.561 SEK
BB Middle7.684 SEK
BB Lower6.807 SEK
BB Width22.83%
ATR (14)0.3852 SEK
Vol Ratio (20d)0.72x